Re:AI in drug discovery is overhyped: examples from AstraZen...
by technics256 on Sunday January 07, 2018 @05:50AM
(#16090324)
They are, but you have to realize that the companies themselves are focused on healthcare first, and reimbursement. Healthcare in the United States is a fee for service model, not a value based one. So the system isn't aligned for it. But they are doing it, look at the sepsis NLP solution created by Mass General in-house.
[ Parent
| on HN ]
There are no comments on this comment yet.